Detalles de la búsqueda
1.
Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 28(9): 812-822, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37011230
2.
Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.
Br J Cancer
; 122(12): 1872, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303715
3.
Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.
Br J Cancer
; 121(7): 600-610, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31481733
4.
Efficacy and safety analysis of prucalopride in refractory chronic constipation cases in a tertiary care hospital in Eastern India: A randomized, single-blind, placebo-controlled study.
Indian J Pharmacol
; 55(1): 6-13, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36960515
5.
An Analysis of Clinical and Systemic Factors Associated with Palliative Radiotherapy Delivery and Completion at the End of Life in Alberta, Canada.
Curr Oncol
; 30(12): 10043-10056, 2023 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38132364
6.
Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma.
Curr Oncol
; 30(10): 8936-8947, 2023 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37887546
7.
Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors.
JTO Clin Res Rep
; 4(4): 100482, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37090101
8.
Analysis of adverse drug reactions of imatinib in chronic myeloid leukemia patients: An Eastern Indian experience.
Indian J Pharmacol
; 54(5): 349-352, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36537404
9.
Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab.
Curr Oncol
; 29(10): 7695-7704, 2022 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36290885
10.
Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy.
JAMA Netw Open
; 5(12): e2245596, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36480204
11.
Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors.
Cancer Med
; 10(8): 2618-2626, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33724676
12.
Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database.
Curr Oncol
; 28(5): 4213-4222, 2021 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34677275
13.
Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials.
Eur J Cancer
; 151: 115-125, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33975059
14.
ATM-Deficient Cancers Provide New Opportunities for Precision Oncology.
Cancers (Basel)
; 12(3)2020 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32183301
Resultados
1 -
14
de 14
1
Próxima >
>>